BRC Therapeutics
PrivateLast Round
Series A
Oct 4, 2022
Total Funding Raised
$20M
Company Overview
BRC Therapeutics is a pharmaceutical company focused on developing proprietary cannabinoid therapeutics to address pain and neurological conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BRC Therapeutics Comps
Public and private peers based on sector, stage, and business model.
BRC Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 4, 2022 |
BRC Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Achari Ventures | Series A |
| Intrinsic Capital Partners | Series A |
| Delta Emerald Ventures | Series A |
| Argonautic Ventures | Series A |
| AFI Capital Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 14, 2025
Dr. Stephen Wright joins as Advisor in Drug Development.
BRC Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BRC Therapeutics's valuation, stock price, and market status.
